DEPENDENCY OF OSTEOCLAST DIFFERENTIATION ON EXOGENOUS CHOLESTEROL AND ROLE OF CAVEOLIN-1 IN OSTEOCLASTOGENESIS
DEPENDENCY OF OSTEOCLAST DIFFERENTIATION ON EXOGENOUS CHOLESTEROL AND ROLE OF CAVEOLIN-1 IN OSTEOCLASTOGENESIS
批准号:
21592341
负责人:
HAKEDA Yoshiyuki
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To elucidate the cellular and molecular mechanisms underlying the high dependency of osteoclastogenesis on exogenous cholesterol and the role of a major scaffold protein in lipid rafts, caveolin-1(Cav-1), in osteoclast differentiation, we examined in vitro osteoclast formation and in vivo bone morphometrical analysis using low-density lipoprotein receptor(LDLR) knockout(KO) and Cav-1 mice. In this study, we found that osteoclast formation strictly required the uptake of exogenous cholesterol via LDLR and that LDLR deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion. In addition, in vitro osteoclastogenesis of precursor cells from Cav-1-null mice was comparable to that of wild-type mice, while Cav-2 expression in the knockout osteoclasts was maintained. Conversely, Cav-2 gene silencing in Cav-1-null osteoclast precursors using siRNA for Cav-2 increased osteoclast formation, suggesting that the Cav-1/Cav-2 complex may acts as a negative regulator for osteoclastogenesis. Taken together, these findings provide a novel mechanism for osteoclast differentiation and improve the understanding of the correlation between osteoclast formation and lipids.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Osteocytic MLO-Y4 cells inhibit osteoclastogenesis by a soluble factor(s), independent of modulation of RANKL/OPG productions by stromal cells
骨细胞 MLO-Y4 细胞通过可溶性因子抑制破骨细胞生成,与基质细胞对 RANKL/OPG 产生的调节无关
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[Ichinohe, N., Ohara-Nemoto, Y., Nemoto, T.K., Kimura, S., Ichinohe, S., 羽毛田慈之]
通讯作者:
羽毛田慈之
Low Density Lipoprotein Receptor欠損マウス(LDR-KO)における破骨細胞融合障害と骨量増加
低密度脂蛋白受体缺陷型小鼠 (LDR-KO) 破骨细胞融合受损和骨量增加
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[Yuji Seta, Masafumi Oda, Takashi Toyono, Shinji Kataoka, Kuniaki Toyoshima, 岡安麻里]
通讯作者:
岡安麻里
Highly-requirement of exogenous cholesterol and positive role of lipid raft for osteoclast differentiation
外源胆固醇的高需求和脂筏对破骨细胞分化的积极作用
DOI:
--
发表时间:
2010
期刊:
影响因子:
--
作者:
[瀬田祐司, 小田昌史, 豊野孝, 片岡真司, 豊島邦昭, 羽毛田慈之]
通讯作者:
羽毛田慈之
Receptor activator of NF-kB ligand-dependent expression of caveolin-1 in osteoclast precursors and high dependency of osteoclastogenesis on exogenous lipoprotein
破骨细胞前体细胞中 NF-kB 配体依赖型 Caveolin-1 表达的受体激活剂以及破骨细胞生成对外源性脂蛋白的高度依赖性
DOI:
--
发表时间:
2012
期刊:
Bone
影响因子:
4.1
作者:
[Hada N, Okayasu M, Ito J, Nakayachi M, Hayashida C, Kaneda T, Uchida N, Muramatsu T, Koike C, Masuhara M, Sato T, Hakeda Y]
通讯作者:
Hakeda Y
マウス長骨からの骨細胞の分離方法の検討
小鼠长骨骨细胞分离方法的研究
DOI:
--
发表时间:
2011
期刊:
影响因子:
--
作者:
[林田千代美, 佐藤卓也, 中谷地舞, 伊東順太, 岡安麻里, 羽毛田慈之]
通讯作者:
羽毛田慈之
共 13 条
Elucidation of Involvement of LOX-1 in inflammatory bone destruction and the molecular mechanism for the LOX-1 actions, and an approach to develop the new drug for bone diseases.
-
批准号:16H05505
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.07万
-
财政年份:2016
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Trial study for the establishment of the new therapeutical method for periodontal disease that targets oxidation LDL receptor LOX-1.
-
批准号:26670895
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
The elucidation of the role of lipid in bone resorption of inflammatory bone diseases; in particular, the exploration of the role of LOX-1 as an oxidized LDL receptor
-
批准号:25293376
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2013
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Elucidation on roles of caveolae/lipid raft on osteoclast differentiation and bone resorption and on intracellular trafficking of caveolin-1
-
批准号:19592130
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Investigation of action of shear stress, which is produced by Mechanical loading applied to the skeleton, on osteodast formation and bone-resorbing activity
-
批准号:17591922
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2005
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Elucidation of role of beta ig-3 derived from osteoclasts in bone resorption and formation
-
批准号:15591946
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Elucidation of regulatory mechanism of osteoclast differentiation and function by extracellular calcium and phosphorus.
-
批准号:12671780
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.92万
-
财政年份:2000
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Study on direct action of estrogen on mature osteoclasts
-
批准号:08672087
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1996
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
Analysis of osteoclast-specificmembrane-bound proteins that are expressed during osteoclast differentiation
-
批准号:06671825
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:HAKEDA Yoshiyuki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
雷公藤红素抑制Caveolin-1乙酰化修饰调控线粒体铁代谢诱导铁死亡抗肾癌研究
-
批准号:2025JJ60646
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张婵娟
-
依托单位:
姜黄素烟酸酯经Caveolin-1/ERK/AP-1通路调控血管平滑肌细胞增殖影响动脉粥样硬化病变研究
-
批准号:2025JJ70208
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:阳巍
-
依托单位:
Caveolin-1-Stat3促进N1型中性粒细胞
分化加重牙周炎的作用机制及靶向治疗
研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:王盼盼
-
依托单位:
微凹蛋白caveolin-1在囊泡与血管内皮细胞被激活后诱发的CRS及ICANS的机制研究
-
批准号:JCZRLH202500684
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
姜黄素通过调控 Caveolin-1 抑制内皮细胞焦亡抗动
脉粥样硬化
-
批准号:2024JJ5301
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:卜兰兰
-
依托单位:
Caveolin-1调控多发性骨髓瘤细胞表面CD38水平的机制及其在达雷木单抗敏感性调节中的作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:15.0万元
-
批准年份:2024
-
负责人:王金恒
-
依托单位:
白藜芦醇通过小窝蛋白(Caveolin-1)内吞抗肺间质纤维化的分子机制研究
-
批准号:
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨慧龄
-
依托单位:
CD147通过Caveolin-1介导内皮细胞损伤参与异种肝移植急性体液性排斥反应的机制研究
-
批准号:82302005
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王权成
-
依托单位:
血管内皮Caveolin-1介导脑缺血再灌注后出血转化的机制研究
-
批准号:82371311
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:张晓浩
-
依托单位:
TRAF6/Caveolin-1/p62功能轴介导高自噬水平CAFs与肿瘤细胞形成“代谢耦连”关系影响胰腺癌侵袭转移的机制研究
-
批准号:82372964
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:孟庆才
-
依托单位: